Mycrodose Therapeutics

Mindstate

This pharmaceutical company develops designer psychedelic compounds using artificial intelligence to treat mental health conditions such as treatment-resistant post-traumatic stress disorder.

GH Research

This pharmaceutical company develops psychedelic-based therapies for patients suffering from psychiatric and neurological disorders, including treatment-resistant depression.

Mindstate Design Labs

This biotechnology company develops custom psychedelic therapeutics using an artificial intelligence platform to treat mental health conditions for patients with various psychiatric disorders.

Small Pharma Limited

This clinical-stage biotechnology company develops psychedelic-based medicines and DMT therapies for patients with major depressive disorder and other mental health conditions.

Enabling psychedelics-assisted therapies

This biopharmaceutical company develops psychedelic-inspired medicines and a care delivery model to treat addiction for patients and healthcare providers.

Delix

This company develops non-hallucinogenic neuroplasticity-promoting medicines to treat neuropsychiatric and neurodegenerative conditions for patients with brain disorders.

Reunion Neuroscience

This biopharmaceutical company develops psychedelic-inspired therapeutic solutions for patients with underserved mental health disorders, such as postpartum depression and anxiety.

Delix Therapeutics

This biotechnology company develops non-hallucinogenic neuroplasticity-promoting medicines to treat patients with neuropsychiatric and neurodegenerative conditions.